| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |